Healthcare Global Enterprises' Q3 FY 2025-26 Quarterly Results
- 06 Feb 2026
Result Summary
- Healthcare Global Enterprises Ltd reported a 2.1% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 12.8%.
- Its expenses for the quarter were down by 0.2% QoQ and up 10.8% YoY.
- The net profit decreased 138.2% QoQ and decreased 201.9% YoY.
- The earnings per share (EPS) of Healthcare Global Enterprises Ltd declined at 0.68 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 635.54 | 649.47 | 563.21 | -2.1% | 12.8% |
Total Expenses | 628.89 | 629.96 | 567.41 | -0.2% | 10.8% |
Profit Before Tax | -6.02 | 19.51 | -4.20 | -130.9% | 43.3% |
Tax | 1.83 | -0.84 | -11.05 | -317.9% | -116.6% |
Profit After Tax | -7.90 | 20.66 | 7.75 | -138.2% | -201.9% |
Earnings Per Share | -0.68 | 1.16 | 0.49 | -158.6% | -238.8% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Healthcare Global Enterprises Ltd is a company primarily engaged in providing healthcare services. It operates within the medical and healthcare industry, focusing on delivering specialized healthcare services, particularly in oncology. As of the latest data, no specific recent major developments within the company are available. Healthcare Global Enterprises Ltd typically offers services related to cancer treatment, advanced medical care, and other healthcare services. The company has established a network of hospitals and clinics that cater to a broad spectrum of healthcare needs, with a significant emphasis on oncology services, which positions it as a notable entity in the healthcare sector.
Revenue
For the third quarter of the fiscal year 2026, Healthcare Global Enterprises Ltd reported a total income of ₹635.54 crores. This represents a decrease of 2.1% compared to the previous quarter (Q2FY26), which saw a total income of ₹649.47 crores. However, on a year-over-year basis, there is an increase of 12.8% from the third quarter of the fiscal year 2025, where the total income was ₹563.21 crores. The data indicates variations in the company's quarterly and annual revenue figures, reflecting fluctuations in financial performance over these periods.
Profitability
The financial data reveals that Healthcare Global Enterprises Ltd experienced a loss in its profitability during the third quarter of the fiscal year 2026. The company reported a profit before tax of -₹6.02 crores, a significant decline from the previous quarter's profit of ₹19.51 crores. On a year-over-year comparison, the profit before tax shows a decline from -₹4.20 crores in Q3FY25. The tax expenses for Q3FY26 were ₹1.83 crores, contrasting with a tax benefit of -₹0.84 crores in Q2FY26 and -₹11.05 crores in Q3FY25. Consequently, the profit after tax for Q3FY26 stood at -₹7.90 crores, compared to ₹20.66 crores in Q2FY26 and ₹7.75 crores in Q3FY25. This reflects a substantial decrease in profitability on both a quarterly and annual basis.
Operating Metrics
The company's earnings per share (EPS) for Q3FY26 was reported at -₹0.68, indicating a decline from ₹1.16 in the previous quarter and ₹0.49 in the same quarter of the previous year. The quarter-over-quarter change in EPS is -158.6%, while the year-over-year change is -238.8%. These figures suggest significant changes in shareholder value over the analyzed periods. Additionally, total expenses for Q3FY26 were ₹628.89 crores, showing a slight decrease of 0.2% from Q2FY26. However, when compared to Q3FY25, total expenses increased by 10.8%. The financial performance in terms of expenses and earnings highlights the company's operational challenges during the specified periods.